Further information

This chapter provides an overview of key evidence, strategies and technology in the microbicides field.  Below is some suggested reading on other vital aspects of the field:

Assessing and optimising levels of adherence in microbicide trials

Tolley EE, Harrison PF, Goetghebeur E, et al. Adherence and its Measurement in Phase 2/3 Microbicide Trials. AIDS Behav. 19 November 2009. Available on line at http://www.springerlink.com/content/t508k0uj27074305/.

Care and services provided to microbicide trial participants

Heise L, Shapiro K, and West Slevin K Mapping the Standards of Care at Microbicide Clinical Trial Sites. Global Campaign for Microbicides, Washington DC, February 2009. Available on line at http://www.global-campaign.org/clientfiles/SOC.pdf

Civil society participation in microbicides advocacy

Forbes A, Sylla L, Yassky R The First 55 Steps: A Report of the Microbicide Development Strategy’s Civil Society Working Group. Global Campaign for Microbicides, Washington DC, February 2008. Available on line at http://www.global-campaign.org/clientfiles/GCM-MDS-CSWG-FinalReportFeb2008.pdf

Ethical issues raised in the conduct of microbicide trials

Global Campaign for Microbicides Rethinking the Ethical Roadmap for Clinical Testing of Microbicides: Report on an International Consultation. Global Campaign for Microbicides, Washington DC, March 2005. Available on line at http://www.global-campaign.org/EngDownload.htm#ethics.

Financial and decision-making challenges to setting the microbicide research agenda

Stone A, Harrison PF Microbicides – Ways Forward. Alliance for Microbicide Development, Silver Spring, MD, 2010. Available on line at http://www.avac.org/ht/a/GetDocumentAction/i/27266

HIV-positive women and microbicides: concerns and priorities

Global Network of People Living with HIV, International Community of Women Living with HIV and AIDS, Global Campaign for Microbicides. HIV Positive Women and Microbicides. March 2009. Available on line at http://www.gnpplus.net/programmes/positive-health-dignity-and-prevention/new-prevention-technologies/1536-factsheet-on-microbicides-and-hiv-positive-women.

Rectal microbicides: status of development

LeBlanc M From Promise to Product: Advancing Rectal Microbicide Research and Advocacy. International Rectal Microbicides Advocates, Chicago, May 2010.  Available on line at http://www.rectalmicrobicides.org/docs/From%20Product%20to%20Promise%20FINAL%20English%20version/FINAL_eng_IRMA_2010.pdf

Sex workers and microbicides: concerns and priorities

Forbes A Sex Workers and Microbicides: An Advocacy Brief.  Endorsed by multiple sex worker advocacy organisations globally. May 2010. Available on line at http://sexworkersproject.org/downloads/2010/m2010-microbicides-advocacy-brief.doc

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.